2.4. Assessment of Whole-Body Glucose Tolerance

KD Kristyn Dunlop
OS Ousseynou Sarr
NS Nicole Stachura
LZ Lin Zhao
KN Karen Nygard
JT Jennifer A. Thompson
JH Jennifer Hadway
BR Bryan S. Richardson
YB Yves Bureau
NB Nica Borradaile
TL Ting-Yim Lee
TR Timothy R. H. Regnault
ask Ask a question
Favorite

At PND60 and PND120, intraperitoneal glucose tolerance tests (IPGTTs) were performed to assess whole-body glucose tolerance. Following an overnight (16 h) fast, baseline glucose was measured and a bolus injection of 50% dextrose (1 g/kg body weight) was immediately administered intraperitoneally. Blood was sampled at the peripheral ear vein every 10 min during the 20 min post-injection and thereafter every 30 min (0-, 10-, 20-, 50-, 80-, 110-, 140-, 170-, and 200 min). Blood glucose levels were measured using a Bayer Contour hand-held glucometer (Bayer Diabetes, Mississauga, ON, Canada). Area under the glucose curve was calculated using GraphPad Prism 6 (GraphPad Software, San Diego, CA, USA) for each animal as a measure of glucose clearance [50].

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A